Delivery Order SPE2DB24D2216-SPE2DB26FGLYM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,990.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price, non-competitive delivery order represents a small-value pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,456.89 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,891.31 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under DLA's broader medical supply chain operations. The contract is classified as a child award, indicating it derives from a larger indefinite delivery vehicle. Performance will be executed from...
- The Defense Logistics Agency awarded a $2,419.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with an ultimate completion date of June 17, 2025 will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors. This firm fixed-price delivery order, issued on September 3, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency (DLA) awarded a $4,081.35 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections on April 25, 2025, with completion scheduled for April 28, 2025. This firm fixed price contract represents a child order under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and running through December 2026. The delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $9,251.06 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,725.16 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract is classified as firm fixed price and carries an ultimate completion date of September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB26FGLYMDelivery Order
The Defense Logistics Agency (DLA) awarded a $15,240.97 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml) pharmaceutical supplies. This competitively awarded, firm fixed-price delivery order is classified as a child contract under AmerisourceBergen's broader indefinite delivery vehicle with DLA and carries an ultimate completion date of October 20, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's comprehensive IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle supplying military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of medications and medical supplies to defense and veteran healthcare systems. The Mounjaro supply delivery supports the Defense Health Agency and broader military medical supply chain requirements for diabetes management medications within the DLA's pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 10/17/25 |